Lionel Wightman

Biography

Dr Lionel Wightman joins AOP Orphan as of 1st January 2017. He has a scientific background gaining a Welcome Trust Prize PhD studentship studying Prion diseases and received a degree in Applied Biology from Imperial College, London. Lionel has over 20 years’ experience, and his last positions were Chief Administrative Officer (CAO), then CEO at Akron Molecules GmbH focused on the treatment of pain and the CEO of Activartis Biotech GmbH, a cancer vaccine company. Other positions held previously include Head of Operations and Finance at F-Star GmbH, focused on the development of bi-specific antibodies; and Oridis Biomed GmbH, a company focused on liver diseases. Lionel was also employed by Boehringer Ingelheim in the biopharmaceutical production unit; and as a research scientist in the areas of cancer vaccines and gene therapy.

Research Interest

healthcare